TAM
CLVS

Tocqueville Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Tocqueville Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,400
Closed -$246K – 856
2018
Q2 		$246K Sell
5,400
-38,925
-88% -$1.89M ﹤0.01% 739
2018
Q1 		$2.34M Sell
44,325
-10,455
-19% -$610K 0.03% 416
2017
Q4 		$3.73M Sell
54,780
-28,355
-34% -$1.98M 0.04% 372
2017
Q3 		$6.85M Buy
83,135
+26,010
+46% +$2.06M 0.08% 266
2017
Q2 		$5.35M Buy
57,125
+31,175
+120% +$1.91M 0.06% 282
2017
Q1 		$1.65M Buy
25,950
+12,225
+89% +$743K 0.02% 435
2016
Q4 		$610K Sell
13,725
-28,775
-68% -$1.01M 0.01% 565
2016
Q3 		$1.53M Buy
+42,500
New +$912K 0.02% 446
2016
Q1 		– Sell
-6,500
Closed -$228K – 935
2015
Q4 		$228K Sell
6,500
-33,180
-84% -$2.14M ﹤0.01% 825
2015
Q3 		$3.65M Buy
39,680
+975
+3% +$84.4K 0.05% 339
2015
Q2 		$3.4M Buy
+38,705
New +$3.31M 0.04% 381
2014
Q3 		– Sell
-4,200
Closed -$174K – 1356
2014
Q2 		$174K Sell
4,200
-2,700
-39% -$139K ﹤0.01% 997
2014
Q1 		$478K Buy
6,900
+2,800
+68% +$206K 0.01% 585
2013
Q4 		$247K Buy
+4,100
New +$223K ﹤0.01% 754

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Tocqueville Asset Management's CLVS Position: Q3 2018 in Review

Tocqueville Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2018, closing a stake of 5,400 shares — an estimated $246K sold.

Tocqueville Asset Management first reported a position in CLVS in Q4 2013 and held it in 14 quarters. The position peaked at $6.85M in Q3 2017. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2018.

  • Tocqueville Asset Management reported no remaining Clovis Oncology, Inc. position as of Q3 2018 after selling out during the quarter.
  • Tocqueville Asset Management sold 5,400 Clovis Oncology, Inc. shares in Q3 2018, an estimated $246K.
  • Tocqueville Asset Management first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 14 quarters.
  • Tocqueville Asset Management's Clovis Oncology, Inc. position peaked at $6.85M in Q3 2017.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2018.

Based on Tocqueville Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.